A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Shaare Zedek Medical Center ( Site 0603), Jerusalem, Israel

Haddasah Medical Center ( Site 0600), Jerusalem, Israel

Sheba Medical Center ( Site 0601), Ramat Gan, Israel

Sourasky Medical Center. ( Site 0604), Tel Aviv, Israel

Colorado Blood Cancer Institute ( Site 7000), Denver, Colorado, United States

SCRI Oncology Partners ( Site 0100), Nashville, Tennessee, United States

Instituto Alexander Fleming ( Site 1404), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Sanatorio Nuestra Senora del Rosario ( Site 1403), Rosario, Santa Fe Province, Argentina

Beijing Cancer hospital ( Site 1701), Beijing, Beijing Municipality, China

INOC - Istituto Nazionale Oncologico Candiolo ( Site 0701), Candiolo, Piedmont, Italy

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( Site 0900), Warsaw, Masovian Voivodeship, Poland

Pratia Onkologia Katowice ( Site 0902), Katowice, Silesian Voivodeship, Poland

Institut Català d'Oncologia (ICO) - Badalona ( Site 1103), Badalona, Barcelona, Spain

Hospital Virgen de la Victoria ( Site 1104), Málaga, Malaga, Spain

Hospital Universitari Vall de Hebron ( Site 1102), Barcelona, Spain

Hospital Universitario Gregorio Maranon ( Site 1101), Madrid, Spain

Hospital Universitario 12 de Octubre ( Site 1105), Madrid, Spain

Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 1000), Ankara, Turkey (Türkiye)

Koç Üniversitesi Hastanesi ( Site 1001), Istanbul, Turkey (Türkiye)

Derriford Hospital ( Site 1304), Plymouth, Devon, United Kingdom

The Christie NHS Foundation Trust ( Site 1300), Manchester, United Kingdom